• Top Posts

Shyness is not social phobia, social phobia is shyness

A recent report from Reuters bore the heading ‘Social phobia’ not shyness, researchers say.

The biggest non-story around is this study done in order to make social phobia out to be something other and more insidious than shyness. Guess what? The researchers got the results they wanted, and they declared social phobia more distressing than mere shyness. Big surprise, huh? Oh, and get this, social phobia is a legitimate psychiatric condition whereas shyness is not a legitimate psychiatric condition. As they are not going to conduct a study to prove the non-serious nature of shyness, I’d call that conclusion more bullshit in the bullshit department.

“I think their article is a welcome reminder that psychiatric diagnoses aren’t some kind of conspiracy on the part of the pharmaceutical industry,” said Ian Dowbiggin, a historian and the author of The Quest for Mental Health: A Tale of Science, Medicine, Scandal, Sorrow, and Mass Society.

Well, excuse me, Mr. Dowbiggin! Do you think these poor poor pathetic subhuman little student types should be institutionalized for their oh-so-monumental phobias? It must be remembered here that phobia is doctor-speak for fear, and fear the cough cough “disease” is more common than the common cold. Fear, in fact, remains an emotion quite common to the human experience. The pathologizing of that common emotion is the matter that concerns me here.

Around half of the more than 10,000 U.S. teens interviewed in the survey said they were shy to some degree, whereas only about nine percent met the criteria for social phobia.

One in eight of the self-described shy children were estimated to have had social phobia, also called social anxiety disorder, at some point. That compared to one in 20 of those who weren’t shy.

The growing up experience might be described as the process of overcoming, and learning to deal with, one’s fears, anxieties, and phobias. Pathologising human emotions has become a way of insuring that the follies of youth and naivety don’t give way to the wisdom of age and experience. In other words, turning emotion into pathology is a way of avoiding the maturation process.

Adolescents can be shy, and adolescents can have anxiety. Neither shyness nor fears nor anxieties are diseases until psychiatrists get a hold of them, pronounce them such, and catalogue them in their bible, the DSM.

I’ve read where some shrinks would characterize diagnosis as closer to an art than a science. Okay, I can buy that. Whether we call it shyness, social phobia, generalized anxiety disorder, or social anxiety disorder I kind of think the boundaries have become blurred between this, that, and the other. What’s more, I think drug companies out to expand their markets, and increase their sales, have had a heck of a lot more to do with this blurring of the lines than somebody would like to let on.

Look incredulous.

Report claims half the people in the USA bonkers

A story in DoctorsLounge.com, Half of Americans Will Suffer From Mental Health Woes, CDC Says, covers a new report by the Center for Disease Control and Prevention that claims about ½ the people in the USA will experience a mental health problem at some point in their lives.

About half of Americans will experience some form of mental health problem at some point in their life, a new government report warns, and more must be done to help them.

Given that the USA is at the epicenter of the current WORLDWIDE epidemic in psychiatric disability, I don’t really find this statistic all that surprising. Pharmaceutical companies must sell pharmaceutical products, and as a result of this advertising frenzy, the USA has become the leading example of a growing prescription drug culture.

Straight off I can see 3 obvious reasons for this epidemic that many mental health professionals are apparently fain to spot. 1. direct to consumer advertising (legal only in the USA and New Zealand) by drug manufacturers, 2. mental health screening programs (they have incredibly high false positive rates), and 3. patient advocacy group anti-stigma campaigns (when having a “mental illness” becomes cool and trendy, there will be more people claiming to have one.).

There are “unacceptably high levels of mental illness in the United States,” said Ileana Arias, principal deputy director of the CDC. “Essentially, about 25 percent of adult Americans reported having a mental illness in the previous year. In addition to the high level, we were surprised by the cost associated with that — we estimated about $300 billion in 2002.

Did you get that! About ¼ of the adult population of the USA reported having a “mental illness” last year. They are also talking costs, estimated at $300,000,000,000. Well, I know that so-called “serious mental illness”, lifelong disability, can be very expensive. Add to it doctor visits for the psychiatric equivalent of the common cold, and you’re still talking money down the tubes.

“Mental illness is frequently seen as a moral issue or an issue of weakness,” Arias explained. “It is a condition no different from cancer or other chronic diseases. People need to accept the difficulties they are having and avail themselves of the resources that are available.”

Ileana Arias says a lot of things on this subject in this article, and every time she says something, I feel like cracking up. If she’s saying that ½ the people in the USA are going to have a brain disease, I think she must be as batty as some of the people psychiatry treats. More to the point, if ½ the people in the USA will have “mental illness” at some point in their lives, that “mental illness” has more to do with a lapse in moral fortitude and strength of character than it does with any inheritable disease.

The report says 5 % of the nation’s population was labeled “seriously mentally ill”, that is, unable to function, at some point last year. That would be about my estimate, too. This figure I expect to climb even further in the future.

The question I have to ask is what is making the USA such a difficult country to live in? When this article claims 8.4 million people had suicidal thoughts last year. Shrug. I imagine the real figure to be a bit higher. 2.2 million made plans to kill themselves, and 1 million attempted suicide. Attempting suicide, unlike succeeding, will get anyone a psychiatric label. This article doesn’t explain how we make this country a more livable place for the vast majority of people who inhabit it, and that, I think, is the question you have to ask before you can expect the emotional turmoil rate to go down.

The absolutely amazing thing is you’ve got this report saying 50 % of the people in the USA will experience mental health issues during their lifetimes, and this shrink in the same article says under-diagnosis and under-treatment is a big problem! Uh, I don’t think so. Remember with nostalgia the silent majority then, and welcome the new Mad Majority. Half of the people of the USA is two thirds of the way to 75 % of the people in the USA. I guess our movement must be making progress.

Dumb Teens Make Stupid DVD

You gotta wonder what they’re teaching kids these days. Here, for example, is an article with the heading, Teens make DVD about mental illness [http://www.courant.com/health/fl-hk-teen-mental-illness-20110823,0,6169683.story]. I don’t intend to view it, but given a little bit of imagination you can come up with your own distressing scenarios. Guess what we learned in school today, Mom? We learned I have a serious mental illness.

“My hope is that one day we talk about mental illness as much as we talk about cancer, as a disease,” said Haylee Becker, 17, a 2011 graduate of Atlantic High School in Delray Beach who has been diagnosed with depression and bipolar disorder. “It’s too late for the school system to do things for me that would have made me healthier, but I hope they can start intercepting other kids at a younger age.”

I’ve got news for you, Haylee. Cancer is an illness; mental illness is a semantically incorrect mishmash. Talking about cancer may not make the cancer go away, but talking about mental illness is definitely not going to make the delusions go away. Maybe the schools ought to start “intercepting” a few fewer kids at younger and younger ages than they do now.

Puberty and adolescent rebellion hit almost simultaneously, and the next thing you know, this girl is ‘off her meds’. At 15, not only does she have fewer rights as a child, but she has even fewer rights as a result of psychiatric labeling and oppression.

When she turned 13, Becker said, she started hating school and began skipping it. At 15 and 16, therapists ordered her into institutions because she was not taking her medications and had lengthy episodes of crying and refusing to get out of bed.

Where mom and dad were at this time, who knows? As the medical model propaganda tells us, they couldn’t have been at all responsible.

Given counseling and psychiatric drugs, Haylee Becker, reports that she has learned to accept her disability. Great lesson, kid! This business of accepting the suggestion made that you have a disability. Uh, or do I mean excepting? Now, do you have any abilities to report as well?

The real clincher is right here…

Mental illness among teens is more common than many people realize. One in 10 children and teens is depressed at any moment, according to the Substance Abuse and Mental Health Services Administration. Almost 5 percent have Attention Deficit Hyperactivity Disorder, and another 5 percent Oppositional Defiant Disorder, or hostility to authority figures. Eating disorders affect about 2 percent of teens, while conduct disorders touch up to 4 percent.

They’re selling psychiatric drugs, and they can’t sell psychiatric drugs without selling mental illness. One of the fastest growing markets for psychiatric drugs today is among children and adolescents. These teens have, unwittingly perhaps, jumped onto the drug manufacturer’s band wagon.

If it weren’t for multiple labels, so called co-occurring disorders, these percentages would add up to an incredible 26 %. Some psychiatrists like to make people look really messed up by claiming they have more than one disorder. This also gives them the opportunity to resort to the very ineffective, but potentially very damaging, practice of polypharmacy, or putting people on mixed psychiatric drug cocktails.

The problem, as it stands, is that Miss Becker and the other teens involved in this project will probably be continuing to receive “help”. For many teenagers with “mental illness” labels, in fact, there is a possibility that this “help” will extend to the end of their days. Given this reality, I feel like I must give my thumbs up to teens that have a completely different message to convey.

Massachusetts Sues Johnson and Johnson

Bloomberg covered a story of the kind that I’d like to see more of in this nation, Massachusetts Sues J & J Over Risperdal Marketing Practices. Yes, that’s right. A state is suing a drug company over its fundamentally illegal marketing practices. Here’s a case of a drug company potentially getting penalized for the illegal practice of promoting so called ‘off label’ drugging. It’s illegal. Why didn’t the feds think of that?

Massachusetts’s attorney general sued Johnson Johnson’s Ortho-McNeil-Janssen unit for improper marketing of the anti-psychotic drug Risperdal.

Improper marketing is illegal marketing. Killing the elderly and incapacitating or doping up the young are not proper uses for psychiatric drugs.

The company marketed the drug as a treatment for dementia in the elderly and a way to ease various ailments of younger people when those uses hadn’t been approved by the U.S. Food and Drug Administration, Attorney General Martha Coakley said today in a statement.

Risperal, a neuroleptic drug, is the sort of drug approved for use in the treatment of psychosis. While it has been approved for the treatment of psychosis in adults, it has been used for all sorts’ unapproved purposes on young people from ADHD treatment to conduct management. It has also been shown to put elderly patients with dementia at risk for an untimely and early death.

You may be asking why a drug company would resort to illegal marketing practices?

“Janssen’s illegal marketing and sales tactics helped the company generate hundreds of millions of dollars in sales in the Commonwealth,” the complaint states.

Attorney generals from other states should wake up, and consider adopting a good guy role of the sort that Massachusett Attorney General Martha Coakley assumed. While I say that, should an attorney general not take action, it’s always a good time for private citizens to act in the interests of protecting their state’s citizens from the predatory practices of these pharmaceutical companies. When we don’t go after these companies, they literally get away with murder, and not just murder, but multiple murders, time and time again.

“Normal” or “sane” people much more likely to commit murder

A New Jersey newspaper editorial bearing the headline, State funding treatment is a good investment, misses at the math.

Of the roughly 20,000 murders that occur each year in the United States, about 1,000 of them are committed by people with untreated schizophrenia and bipolar disorder, according to the Virginia-based Treatment Advocacy Center.

The Treatment Advocacy Center is a group that lobbies for more forced mental health treatment. The TAC is based in Arlington, Virginia, in the Washington, D.C. area. It is a special interest group lobbying politicians, therefore the northern Virginia location, and it’s proximity to D.C.

1,000 is 5 % of 20,000. 20,000 is 95 % of 1,000. What this statistic shows, and coming from advocates of more forced treatment, is that murders are 95 % more likely to be committed by people without psychiatric labels than by people with psychiatric labels. If murders are 95 % more likely to be committed by people without psychiatric labels than by people with psychiatric labels, the question then becomes what are we doing locking up and drugging people with psychiatric labels? We have much more reason, the above statistic shows, for locking up and drugging people without psychiatric labels.

Second paragraph.

Many, if not all, of these tragedies are preventable.

Who is this editorialist kidding? Himself? The tragedies being referred to here are the 5 % of violent crime attributed to people with psychiatric labels. What are the murders committed by people without psychiatric labels? Comedies? I suspect that if the law treated people without psychiatric labels the way it does people with mental illness labels then everybody would be subject to confinement and forced drugging on the grounds of a potential for future violent criminal behavior.

His point?

Last week, the [New Jersey] state Department of Human Services confirmed that $2 million in the recently signed state budget will be used to begin implementing court-ordered involuntary outpatient care.

Does this guy realize that our nation has a trillion $ federal debt to pay off? This debt is going to sabotage any efficient effort to scapegoat people with psychiatric labels in this fashion. Just try getting more than 2 million dollars when we’re shaving off billions of dollars. We simply don’t have the money to waste pursuing harmless people with hypodermic needles.

Although direct to consumer advertising, mental health screening, ineffective treatments, lack of pretentive measures, and psychiatrist ties to drug companies keep the mental illness labeling rate growing by leaps and bounds, the 5 % of labeled people committing these violent acts falls far short of the 95 % of non-psychiatrically labeled people perpetuating such violent crimes. In a nutshell, the 5 % of people with psychiatric labels who resort to murder are in no danger, for some time to come, of challenging the hegenomy of murder by the 95 % of violent criminals without psychiatric diagnoses.

2 Bad Supreme Court Decisions

The story in the LA Times, Supreme Court sides with pharmaceutical industry in two decisions, was in the first instance about suing over tardive dyskinesia developed by people using Reglan, a drug for digestion.

People in mental health treatment are also at risk for developing tardive dyskinesia due to the neuroleptic drugs some of them are prescribed for psychosis and bipolar mania. Lawyers know better than to try to mount such a defense for them. When they are not accorded the rights of full and complete citizens, of course, they don’t stand much of a chance of winning such a case in court.

Reporting from Washington— The Supreme Court gave the pharmaceutical industry a pair of victories, shielding the makers of generic drugs from most lawsuits by injured patients and declaring that drug makers have a free-speech right to buy private prescription records to boost their sales pitches to doctors.

What kind of “free-speech” is a boughtprivate prescription record”!? (Emphasis added.)

The government just entered the drug selling trade and, frankly, I don’t think that is a place where the government belongs.

The patients, Gladys Mensing and Julie Demahy, developed tardive dyskinesia, a severe neurological disorder, after taking metoclopramide, a generic form of the drug Reglan for digestive problems, including acid reflux. They sued, alleging that the drug maker failed to warn them of the danger of taking this drug for more than 12 weeks. Studies had suggested a potentially increased risk of the condition — and Reglan was eventually required to carry a “black box” warning about it. That wasn’t the case at the time.

Just imagine getting a permanent neurological movement disorder, a physical disability, from the drug you used to treat your gas, and then not being able to sue the company responsible for making it.

This decision means brand name drug makers can be sued, and generic drug makers can’t be sued. Go figure…

In the second decision, the court by a 6-3 vote struck down a Vermont law that barred pharmacies, drug makers and others from buying or selling prescription records from patients for marketing purposes. Vermont’s physicians had sought passage of the law, arguing that their prescriptions were intended for private use of patients and should not become a marketing tool.

Some people could be so desperate as to sell prescription records. You just have to wonder about Supreme Court Justices who are so desperate as to sell their rulings to the highest corporate bidder. I’m still looking for the freedom involved in such puppetry. I’m wondering who our politicians might have sold it to.

Diagnostic fad versus diagnostic fad

I can’t help thinking that maybe poor parenting skills are behind the current epidemic of childhood “mental disorder” labeling. Newsweek just did a story on the trend of labeling children with bipolar disorder in an article titled Mommy, Am I Really Bipolar?

In the autumn of 1994, a novel idea was afoot in my profession. At the annual conference of the American Academy of Child and Adolescent Psychiatry, I attended a workshop on bipolar disorder in children. About 10 of us attended the meeting, held in a small, poorly lit room. Only one or two doctors reported having actually seen a child with bipolar disorder, but we all agreed to keep our eyes open for other sightings.

Bipolar disorder in a child would have been a much rarer sighting for the experts to make in 1994.

Dubious math is then used to offset the 40 fold, that’s 4,000 %, increase in childhood bipolar disorder that occurred in the USA soon after. Sure, childhood bipolar disorder may have increased in some other places, too, but in no other place would it take off like it has in the USA. The birthplace of kiddy bipolar mania was the good ole’ USA, and that is, of course, where as a diagnosis it has met with the most success.

In adults, bipolar disorder is characterized by cycles in which a patient rotates between two extremes, or poles, of feeling: depression and mania. The cycles may vary in length and intensity, but the adult diagnosis depends on clear-cut episodes of behavior that is distinctively different from normal: severe overexcitement or highs that last for weeks, and crushing, painful periods of deep depression that also last for weeks or months. The description of childhood bipolar disorder by its advocates is dramatically different. Where adult bipolar disorder expresses itself in episodic, out-of-character behavior, a child diagnosed with bipolar disorder will have symptoms that characterize the child’s typical behavior. In this telling, an elementary-school-age child with the disorder may be chronically enraged and have several tantrums per day. But this only points to another problem with the diagnosis: it’s nearly impossible to distinguish between children alleged to have bipolar disorder and those with straightforward anger-control issues. The symptoms may look like mania: irritability, distractibility, and talkativeness. But most of these symptoms can easily be matched to less-trendy conditions like attention-deficit/hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). My view is that a diagnosis of bipolar disorder in a child is almost always a case of severe ADHD combined with severe ODD, both fairly common in elementary-school children.

In the “disorder” business, it’s taboo to be caught without a “disorder” on your fingertips, and at your disposal. If it’s not Bipolar Affective Disorder; it must be that other trendy figment of folks collective imagination, Attention Deficit Hyperactivity Disorder. The Attention Deficit Hyperactivity Disorder craze, after all, started long before the Bipolar Affective Disorder craze. This is the primrose path that this bozo leads us down compounding his folly with the addition of another even more dubious disorder, Oppositional Defiant Disorder. ODD is the disobedient children’s disorder that parents have been dreaming about all their lives. ‘You listen to me, kid, or you’re sick!’

I realized this when I met Alexis, a brilliant 11-year-old girl from a prominent family. She was a talented artist who spent her sessions with me crafting elaborate Renaissance-like drawings and discussing her rehearsals in an adult Shakespearean troupe. Alexis, however, had always performed poorly at school, refusing to participate in the classroom and opting instead to chat with the adults in the teachers’ lounge. Her constant urge to move, her refusal to do her homework—these suggested evidence of ADHD. Yet her parents, having been told that she had a far more serious (and lofty) disorder, resisted the diagnosis. When they reluctantly allowed me to stop her mood stabilizers and instead prescribe stimulant medication for ADHD, this talented child quickly became a well-functioning girl who participated eagerly and happily in class with her peers. Her parents canceled their plans to dispatch her to a boarding school for the emotionally disabled.

The key to ADHD, and this whole paragraph, comes with the 2nd sentence in it. “Alexis…always performed poorly at school…” ADHD, in theory anyway, is the magical formula for getting students who perform poorly a top grade education. The theory runs that if we just give them speed then they can keep up with their peers. I happen to believe perhaps counseling, tutoring, and a remedial study skills course might take you farther. Of course, such extras come at a price, and it’s cheaper just to drug the child. Oh, and I don’t mean financially either. I mean in terms of effort, authentic concern and expenditure of energy, it’s just so much easier.

Psychiatrist Stuart Kaplan, the author of this rather disappointing piece, at the end points towards Temper Dysregulation with Dysporia (TDD) projected in the upcoming DSM as a corrective to the Childhood Bipolar Disorder fiasco. The TDD disorder label is seen as corrective as if this projection wasn’t likely to lead to yet another trendy disease label for shrinks and drug company exes to bank on. If ADHD had been popular, if kiddy BAD has become popular, just make way for TDD. The reasoning and the charm of it is, it won’t be seen as the “serious” disorder label that Bipolar Disorder is seen as being. If it’s the beginning of a downward spiral, well, it has lot’s of company.

Neuroleptic drugs over-used in California nursing homes

You simply can’t be wishy-washy about using neuroleptic drugs on elderly dementia patients. Unfortunately, many people in the media don’t seem to understand this fact. Take the article, Audit: Common psychiatric meds can be deadly for elderly, about how a government audit led to a report on the damage caused by neuroleptic drugs.

The report released Monday by the Health and Human Services Inspector General’s Office shows that 88 percent of the second-generation antipsychotic drugs prescribed at U.S. nursing homes are for patients with dementia, despite a government warning that such patients face an increased risk of death on such drugs.

Why would the government issue such a warning if patients didn’t face an increased risk of death on such drugs? It wouldn’t.

In California the situation is alarming.

Such medications are prescribed daily to 24,000, or about a fourth, of the 99,000 nursing home residents in the Golden State, federal data shows.

There is absolutely no way that ¼ of the nursing home residents in California have schizophrenia or bipolar disorder, the disorders these drugs supposedly were designed to treat. The use of these drugs is therefor primarily “off label”, or for uses that have not been approved by the FDA.

The report was based on a review of nursing home patient medical records from the first half of 2007. The findings include:

• Fifty-one percent, or $116 million worth, of claims for the medications were “erroneous,” meaning they were not given to patients or did not meet Medicare nursing home prescribing guidelines.
• About 83 percent of claims were for “off-label” uses, meaning they were given to patients for conditions other than the serious mental disorders the drugs were developed to treat.
• Of the 2.1 million elderly nursing home residents, 14 percent had a prescription for an atypical antipsychotic drug between Jan. 1 and June 30, 2007.

The California Advocates for Nursing Home Reform has launched a “Campaign to Stop Drugging” because of this very problem. The advocacy group has published a guide to the public on the subject of protecting the elderly from this kind of drug abuse. The CANHR has also held a conference for elderly advocates, and attempted but failed to pass legislation calling for more rigorous informed consent.

This is not a localized problem, and people in other states need to pay close attention to it. Nursing home residents in all likelihood are being drugged into a premature grave in their states as well.

“Anytime anyone takes a hard look at this, they find terrible things,” [CANHR lawyer Anthony] Chicotel said. “They need to focus attention away from just looking and focus on finding solutions.”

This article ends with a trade group doctor arguing for the use of these deadly chemicals. Relatives need to take note. If you want your elderly relatives around awhile longer, ignore the end of this article. This last word is a drug company promotion that has the potential to kill your loved one. Look for substance in it, and you will find none. Equal time for rich and powerful drug companies is not equal time in actuality. All you have to do to get some idea of what I mean when I say this is to turn on the television set. Direct to consumer advertising has made for a very slippery slope between anybody and truly health-conscious information based decision making. It’s not a good idea to kill your elderly relatives if you have any positive regard for them, and if you can help it. Neuroleptic drugs will do just that.

Not enough bipolar disorder in low income nations spin doctors complain

The USA, at 4.4 %, has the highest ratio of lifetime bipolar disorder in the world. This factoid was exposed recently by a study of 11 nations published in the Archives of General Psychiatry. Unfortunately, rather than seeing the obvious, this study has been slanted into a shrewd maneuver to expand prescription drug markets. At the same time, you can be sure that if drug companies expand those markets into the developing world, the bipolar rate in low income countries is going to go up correspondingly. Why else would an article on this study, missing the statistic from the USA, bear such a misleading headline as Bipolar disorder vastly undertreated?

The eleven countries included in the study were:

Her team conducted surveys of adults in the United States, Mexico, Brazil, Colombia, Bulgaria, Romania, China, India, Japan, Lebanon and New Zealand.

This is the same study that gives India a bipolar disorder rate of .1 %.

There are many reasons for the high rate of bipolar disorder diagnoses in the USA. Let’s cover a few of those reasons. There is anti-stigma campaigning, mental health screening, direct to consumer advertising, psychiatric drugs that trigger mania, etc. Direct to consumer advertising is legal only in the USA and New Zealand. When it comes to direct to consumer advertising, you can’t sell a drug without also selling a “disease”. Mental health screening tests are often designed to discover depression. Mental health screening tests have incredibly high false positive rates. Psychiatric drugs used to treat depression trigger mania. What is so often taken to be bipolar disorder misdiagnosed major depressive disorder is more often than not actually a toxic reaction to certain psychiatric drugs.

Not that long ago, in the 1990s, a Harvard psychiatrist with financial ties to the drug companies developed a theory that much ADHD in this country was actually early onset bipolar disorder. Shortly thereafter it was found that as a result of this change in perspective the childhood bipolar disorder rate in this country had shot up 40-fold. Those psychiatrists in charge of editing the future edition of the DSM, the DSM V, in what looks like a strange case of damage control, have come up with an entirely separate juvenile mental disorder to cover some of the young people who might be so labeled in the future.

Back to the spin put on the study.

They found that less than half of those with bipolar disorder — also known as manic-depressive illness — received mental health treatment during their lifetimes. In low-income countries, only 25.2 percent of bipolar patients said they had any contact with the mental health system.

This begs the issue of what the bipolar rates are in poor countries as opposed to in the developed world. If, as in India, you’re talking 1 in 1000 people, investing in mental health treatment might also prove a way of investing in “mental illness”. Let me be the first to point out that an investment in psychiatric disability, and an investment that would certainly mean more psychiatric disability, is probably not the best kind of investment to make.

Three-quarters of those with bipolar disorder also met the diagnostic criteria for at least one other disorder, with anxiety disorders being the most common shared illness, the team found.

More than ½ said symptoms started in adolescence.

Co-morbidity (multiple diagnoses for a single patient), in the mental health treatment world, is invariably a result of over-diagnosis. The diagnosis of co-occurring disorders we see here serves merely as an excuse for polypharmacy, or the prescribing of multiple psychiatric drugs. It should come as no surprise to anyone that drug companies profit from polypharmacy. It may though come as a surprise to some people that the practice of polypharmacy is notorious for its lack of good outcomes.

Skip this therapeutic version of over kill, spare the patient, spare the country, and spare the world. The gig is up! We know that the treatment pushers of the psychiatric state are desperate for more treatment junkies. The real, and underplayed, story here is still that bipolar disorder rates are so high in the good ole’ US of A.

Watching the psychiatric labeling rate rise, it’s easy to predict a rise in psychiatric labeling

One has to be more than a little wary of any article with the heading Medicating mentally ill children: what parents need to know. My suspicion is that some of these parents need to know a little more than they purport to know. My suspicion is that they also need to look for that knowledge in less typical places than they usually do. There is no wisdom to be gained in simply repeating the same tired adage over and over again ad nauseum.

When schools screen for “mental illness”, the number of kids labeled “mentally ill” is going to go up. When drug companies push pharmaceutical products to child care providers, the number of kids labeled “mentally ill” is going to go up. When good parenting skills cease to be applied in child rearing, the number of kids labeled “mentally ill” is going to go up. This article even does a little bit of the math without acknowledging it.

The article deals at 1 place with 2 kids who received bipolar diagnoses. Hello? Did nobody tell the authors about the bipolar boom we experienced recently as a result of labeling kids once labeled ADHD as early onset bipolar cases. This is the same ADHD that was non-existent 50 years ago. It didn’t exist because it hadn’t been invented. The “sick” excuse didn’t, at that time, exist for academic underachievers and classroom clowns.


It wasn’t a case of bad parenting, or bad kids. In both cases the culprit was bipolar disorder.


“It seems there is a progression of this as it marches down the age route, in that younger children are having more symptoms and signs,” said Dr. P. Brent Petersen, the clinical and medical director of the Pingree Center.

Bipolar disorder and schizophrenia are spreading like wildfire among the very young. The authors of this piece are going to ignore cause and effect, in this instance, just so nobody will have any hard feelings. Psychiatric disorder labels are not infectious. They come in trends perhaps, but they are not infectious.

These psychiatric labels serve as excuses for mental health professionals to use expensive psychiatric drugs on their child patients.

The illnesses can be treated with atypical antipsychotics. And while the FDA has only approved those drugs for adults 18 years old and up, doctors can prescribe them “off label” to children — a decision Dr. Kristi Kleinschmit of the University of Utah Neuropsychiatric Institute does not make lightly.

Prescribing drugs for uses not approved by the FDA, or “off label” prescribing as it is called, is fraud. The doctor who gives a drug for some purpose other than that for which it has been approved is defrauding his clientelle. Snake oil hasn’t been approved by the FDA either.

Rich and poor families alike can have throw away unwanted children, but I think the problem is, of course, bigger where impoverishment exists. The article ends by saying as much.

A Rutgers University study found that low-income kids were four times as likely to receive antipsychotics as privately insured families.

When drugging children in low-income households means more federal benefits, of course, the number of children labeled “mentally ill” is going to go up.